Annexon Inc (ANNX)

$6.24

+0.07

(+1.05%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $6.11
    $6.44
    $6.24
    downward going graph

    2.08%

    Downside

    Day's Volatility :5.12%

    Upside

    3.11%

    downward going graph
  • $1.57
    $8.40
    $6.24
    downward going graph

    74.84%

    Downside

    52 Weeks Volatility :81.31%

    Upside

    25.71%

    downward going graph

Returns

PeriodAnnexon IncSector (Health Care)Index (Russel 2000)
3 Months
31.38%
6.5%
0.0%
6 Months
37.22%
7.1%
0.0%
1 Year
83.23%
9.8%
0.0%
3 Years
-69.63%
14.2%
-20.2%

Highlights

Market Capitalization
642.0M
Book Value
$2.9
Earnings Per Share (EPS)
-1.46
Wall Street Target Price
16.4
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-28.6%
Return On Equity TTM
-50.6%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-128.9M
Diluted Eps TTM
-1.46
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.98
EPS Estimate Next Year
-1.05
EPS Estimate Current Quarter
-0.34
EPS Estimate Next Quarter
-0.36

Analyst Recommendation

Buy
    92%Buy
    7%Hold
    0
    0%Sell
Based on 14 Wall street analysts offering stock ratings for Annexon Inc(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
12
Hold
1
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 162.82%

Current $6.24
Target $16.40

Technicals Summary

Sell

Neutral

Buy

Annexon Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Annexon Inc
Annexon Inc
32.8%
37.22%
83.23%
-69.63%
-70.93%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Annexon Inc
Annexon Inc
NA
NA
NA
-0.98
-0.51
-0.29
NA
2.9
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Annexon Inc
Annexon Inc
Buy
$642.0M
-70.93%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Annexon Inc

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 256.1%

Institutional Holdings

  • FMR Inc

    8.89%

  • Bain Capital Life Sciences Investors, LLC

    8.26%

  • SATTER MANAGEMENT CO., L.P.

    7.03%

  • Bvf Inc

    6.64%

  • Redmile Group, LLC

    5.22%

  • Point72 Asset Management, L.P.

    4.89%

Company Information

our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington’s disease and alzheimer’s disease by targeting complement-mediated neurodegeneration (cmnd).

Organization
Annexon Inc
Employees
70
CEO
Mr. Douglas Love Esq., J.D.
Industry
Health Technology

Discover More

FAQs